Compare Sterling Biotech with SHASUN PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs SHASUN PHARMA - Comparison Results

STERLING BIOTECH     Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH SHASUN PHARMA STERLING BIOTECH/
SHASUN PHARMA
 
P/E (TTM) x -0.4 123.9 - View Chart
P/BV x 0.0 8.5 0.2% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 STERLING BIOTECH   SHASUN PHARMA
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
SHASUN PHARMA
Mar-14
STERLING BIOTECH/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs1194 11.1%   
Low Rs346 7.5%   
Sales per share (Unadj.) Rs26.8214.2 12.5%  
Earnings per share (Unadj.) Rs-15.05.3 -280.3%  
Cash flow per share (Unadj.) Rs-5.515.8 -34.5%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %01.4 0.0%  
Book value per share (Unadj.) Rs54.953.3 102.9%  
Shares outstanding (eoy) m267.8756.62 473.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.30.3 79.4%   
Avg P/E ratio x-0.513.1 -3.5%  
P/CF ratio (eoy) x-1.34.4 -28.8%  
Price / Book Value ratio x0.11.3 9.7%  
Dividend payout %018.7 0.0%   
Avg Mkt Cap Rs m1,8623,958 47.0%   
No. of employees `0001.4NA-   
Total wages/salary Rs m5472,164 25.3%   
Avg. sales/employee Rs Th5,303.3NM-  
Avg. wages/employee Rs Th403.8NM-  
Avg. net profit/employee Rs Th-2,959.0NM-  
INCOME DATA
Net Sales Rs m7,18112,127 59.2%  
Other income Rs m43229 18.6%   
Total revenues Rs m7,22312,356 58.5%   
Gross profit Rs m9471,009 93.8%  
Depreciation Rs m2,543594 428.4%   
Interest Rs m4,377415 1,054.5%   
Profit before tax Rs m-5,931230 -2,582.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,924-73 2,646.2%   
Profit after tax Rs m-4,007302 -1,326.1%  
Gross profit margin %13.28.3 158.5%  
Effective tax rate %32.4-31.7 -102.5%   
Net profit margin %-55.82.5 -2,239.6%  
BALANCE SHEET DATA
Current assets Rs m14,3356,884 208.2%   
Current liabilities Rs m49,8098,456 589.0%   
Net working cap to sales %-494.0-13.0 3,812.0%  
Current ratio x0.30.8 35.3%  
Inventory Days Days40362 654.5%  
Debtors Days Days171108 158.7%  
Net fixed assets Rs m55,4324,970 1,115.3%   
Share capital Rs m268113 236.5%   
"Free" reserves Rs m13,9352,875 484.7%   
Net worth Rs m14,7013,020 486.8%   
Long term debt Rs m9,4781,817 521.5%   
Total assets Rs m73,98813,347 554.3%  
Interest coverage x-0.41.6 -22.9%   
Debt to equity ratio x0.60.6 107.1%  
Sales to assets ratio x0.10.9 10.7%   
Return on assets %0.55.4 9.3%  
Return on equity %-27.310.0 -272.4%  
Return on capital %-6.413.3 -48.2%  
Exports to sales %25.946.4 55.9%   
Imports to sales %0.214.2 1.2%   
Exports (fob) Rs m1,8605,622 33.1%   
Imports (cif) Rs m121,728 0.7%   
Fx inflow Rs m1,8605,843 31.8%   
Fx outflow Rs m252,173 1.1%   
Net fx Rs m1,8353,669 50.0%   
CASH FLOW
From Operations Rs m1,719398 432.3%  
From Investments Rs m-3,148-1,635 192.6%  
From Financial Activity Rs m1,4261,309 109.0%  
Net Cashflow Rs m-371 -4.8%  

Share Holding

Indian Promoters % 33.9 39.2 86.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 3.6 -  
FIIs % 9.9 17.6 56.3%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 39.6 99.2%  
Shareholders   21,482 20,750 103.5%  
Pledged promoter(s) holding % 55.9 12.3 455.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   VENUS REMEDIES  PROCTER & GAMBLE HEALTH  GSK PHARMA  J.B.CHEMICALS  ORCHID PHARMA LTD  

Compare STERLING BIOTECH With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 70 Points Higher; Telecom and Banking Stocks Advance(Closing)

Indian share markets traded on a positive note throughout the day and ended marginally higher. The BSE Sensex rose over 350 points intraday.

Related Views on News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Nov 5, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 5-YR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS